We are live on ! Find out more
AMN icon

AMN Healthcare

346 hedge funds and large institutions have $2.35B invested in AMN Healthcare in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 121 increasing their positions, 140 reducing their positions, and 78 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $11.7M

8.52% less ownership

Funds ownership: 107.77%99.25% (-8.5%)

9% less funds holding

Funds holding: 381346 (-35)

14% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 140

23% less capital invested

Capital invested by funds: $3.05B → $2.35B (-$702M)

42% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 78

Holders
346
Holders Change
-35
Holders Change %
-9.19%
% of All Funds
4.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
45
Increased
121
Reduced
140
Closed
78
Calls
$16.9M
Puts
$11.7M
Net Calls
+$5.16M
Net Calls Change
+$12M
Name Holding Trade Value Shares
Change
Change in
Stake
PAS
251
Park Avenue Securities
New York
$229K -$5.58K -82 -2%
CC
252
Corton Capital
Ontario, Canada
$227K -$98.4K -1,446 -29%
OQS
253
Occudo Quantitative Strategies
Florida
$221K +$16.7K +246 +7%
DekaBank Deutsche Girozentrale
254
DekaBank Deutsche Girozentrale
Germany
$218K -$234K -3,441 -49%
BCI
255
Brinker Capital Investments
Pennsylvania
$217K -$86.7K -1,275 -27%
OPS
256
Orion Portfolio Solutions
Nebraska
$217K -$86.7K -1,275 -27%
AWM
257
Avior Wealth Management
Nebraska
$212K +$108K +1,594 +89%
Cambridge Investment Research Advisors
258
Cambridge Investment Research Advisors
Iowa
$207K -$336K -4,936 -60%
BEI
259
Benjamin Edwards Inc
Missouri
$195K +$51.4K +755 +32%
VI
260
Vestcor Inc
New Brunswick, Canada
$177K
SAM
261
Shell Asset Management
Netherlands
$171K -$22.9K -336 -9%
C
262
Covestor
United Kingdom
$169K +$98.2K +1,444 +116%
Osaic Holdings
263
Osaic Holdings
Arizona
$164K -$677K -9,953 -79%
PFBT
264
Parkside Financial Bank & Trust
Missouri
$159K +$72K +1,058 +71%
IWA
265
Icon Wealth Advisors
Texas
$134K -$5.65K -83 -4%
MLICM
266
Metropolitan Life Insurance Company (MetLife)
New York
$130K -$5.85K -86 -4%
GCM
267
Gladius Capital Management
Illinois
$130K -$3.81K -56 -3%
ECM
268
EMC Capital Management
Texas
$126K +$137K +2,020 New
SPIA
269
Steward Partners Investment Advisory
New York
$124K -$25.9K -381 -16%
PS
270
Principal Securities
Iowa
$118K +$83.9K +1,233 +190%
WAM
271
Wolverine Asset Management
Illinois
$114K -$490K -7,200 -80%
Qube Research & Technologies (QRT)
272
Qube Research & Technologies (QRT)
United Kingdom
$112K -$3.96M -58,173 -97%
SOW
273
State of Wyoming
Wyoming
$65.4K -$183K -2,683 -72%
MFG
274
Mendota Financial Group
Wisconsin
$64.9K -$5.31K -78 -7%
TRCT
275
Tower Research Capital (TRC)
New York
$61.8K -$797K -11,709 -92%

AMN Hedge Fund Activity: Q1 2024 in Review

346 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AMN Healthcare (AMN) for Q1 2024, worth a combined $2.35B — down 23% from $3.05B a quarter earlier.

Sellers outnumbered buyers: 78 funds closed out of AMN and 45 opened new positions — a net loss of 33 holders — while 140 trimmed existing stakes and 121 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $52.1M. The largest seller was Pacer Advisors, exiting entirely with an estimated $105M sold.

  • 346 institutional investors held AMN Healthcare (AMN) as of Q1 2024, down from 381 in Q4 2023.
  • Funds reported $2.35B of AMN Healthcare stock for Q1 2024, down 23% quarter-over-quarter.
  • 45 funds opened new AMN Healthcare positions in Q1 2024 and 78 closed out, a net change of -33 holders.
  • The largest AMN Healthcare buyer in Q1 2024 was Point72 Asset Management, an estimated $52.1M added.
  • The largest AMN Healthcare seller in Q1 2024 was Pacer Advisors, an estimated $105M sold.

Based on aggregated 13F filings for Q1 2024.